OPK Biotech  
OPK Biotech websites
Company Technology Research & Development Hemopure Oxyglobin Contact OPK Biotech
The Company - OPK Biotech - Developing, Manufacturing, Marketing Oxygen therapeutics
Home > Help > Legal Statement

Legal Statement

OPK Biotech aquired the assets of Biopure Corporation, including the facility and intellectual property. OPK Biotech is headquartered in Moscow and operates a manufacturing plant and research laboratories in adjacent facilities in Cambridge MA.

This Web site contains certain forward-looking statements. Forward-looking statements are statements other than historical information or statements of current conditions. These forward-looking statements relate to the plans and objectives of the Company for future operations, including the Company's plans for regulatory approval and its estimates of markets. In light of the risks and uncertainties inherent in all future projections, the inclusion of forward-looking statements in this Web site should not be regarded as a representation by the Company that the objectives or plans of the Company will be achieved.

HBOCLAB.com
is a Resource Guide for individuals interested in the impact of OPK Biotech's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure® also applies to Oxyglobin®.

Learn More
Hemopure
Hemopure® has been used to treat surgical anemia in South Africa since 2001.

Learn More

Oxyglobin
Oxyglobin® Solution

More than
200,000 units
have been
sold in the
United
States and
Europe.

Learn More